Back to MW MARSHALL WACE, LLP

TARATARA
12 quarters

Position history for MWMARSHALL WACE, LLP's holdings in PROTARA THERAPEUTICS INC

Yes. Marshall Wace holds 701,021 shares of TARA (Protara Therapeutics), worth $2.7M, as of its Q2 2026 13F filing. It increased the position from 50,731 shares in Q1 2026. Marshall Wace has held TARA since Q2 2025, across 5 quarterly 13F filings.

Current Value

$2.7M

Current Shares

701,021

Total Value Change

+$2M

Total Shares Change

+658,885

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
701,021
+1281.8%
$2.7M0.0%$3.82
42
2026-Q1
Decreased
50,731
-91.3%
$264,3080.0%$5.21
0
2025-Q4
Increased
584,528
+104.7%
$3.1M0.0%$5.33
43
2025-Q3
Decreased
285,586
-21.2%
$1.2M0.0%$4.35
0
2025-Q2
New
362,526
-
$1.1M0.0%$3.03
35
2024-Q4
Exited
0
-100.0%
$00.0%$5.28
0
2024-Q3
Unchanged
77,351
0.0%
$141,5520.0%$1.83
0
2024-Q2
New
77,351
-
$160,8900.0%$2.08
31
2021-Q4
Exited
0
-100.0%
$00.0%$6.75
0
2021-Q3
Decreased
15,190
-13.1%
$105,0000.0%$6.92
0
2021-Q2
Decreased
17,469
-58.5%
$170,0000.0%$9.74
0
2021-Q1
New
42,136
-
$664,0000.0%$15.74
34

Other major holders of TARA: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., Jupiter Topco LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used